The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 905
ISSUE 905
September 17, 1993
Issue 905
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Tacrine for Alzheimer's Disease
September 17, 1993 (Issue: 905)
Tacrine hydrochloride (Cognex - Parke-Davis), an acridinamine derivative, will soon be available for treatment of cognitive deficits associated with Alzheimer's disease.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.